Eli Lilly and Company (LLY)

Eli Lilly Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	5,240	6,245	5,582	6,194	8,318
Depreciation & Amortization	1,527	1,523	1,548	1,324	1,233
Share-Based Compensation	628.5	371.1	342.8	308.1	312.4
Other Operating Activities	-3,156.1	-552.7	-106.2	-1,326.1	-5,026.8
Operating Cash Flow	4,240	7,586	7,366	6,500	4,837
Operating Cash Flow Growth	-44.10%	2.98%	13.33%	34.38%	-12.45%
Capital Expenditures	-3,447.6	-1,854.3	-1,309.8	-1,387.9	-1,033.9
Acquisitions	-1,044.3	-327.2	-747.4	-849.3	-6,936.9
Change in Investments	-128.7	-244	-166	516.7	456.2
Other Investing Activities	-2,532.1	-1,337.4	-644.3	-538.4	-568.3
Investing Cash Flow	-7,152.7	-3,762.9	-2,867.5	-2,258.9	-8,082.9
Dividends Paid	-4,069.3	-3,535.8	-3,086.8	-2,687.1	-2,409.8
Share Issuance / Repurchase	-750	-1,500	-1,250	-500	-4,400
Debt Issued / Paid	8,650	-62	501.4	291.6	4,685
Other Financing Activities	-335	-308.9	-295.9	-241.6	-200.1
Financing Cash Flow	3,496	-5,406.7	-4,131.3	-3,137.1	-2,324.5
Exchange Rate Effect	168.6	-167.6	-205.7	216	-89.9
Net Cash Flow	751.6	-1,751.5	161.4	1,320	-5,660.7
Free Cash Flow	792.5	5,731	6,056	5,112	3,803
Free Cash Flow Growth	-86.17%	-5.36%	18.48%	34.42%	-11.85%
Free Cash Flow Margin	2.32%	20.08%	21.39%	20.83%	17.04%
Free Cash Flow Per Share	0.88	6.36	6.68	5.63	4.08

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).